Heterodimer formation of wild-type and amyotrophic lateral sclerosis-causing mutant Cu/Zn-superoxide dismutase induces toxicity independent of protein aggregation

Human Molecular Genetics
Heidrun WitanAlbrecht M Clement

Abstract

Recent studies provide evidence that wild-type Cu/Zn-superoxide dismutase (SOD1(hWT)) might be an important factor in mutant SOD1-mediated amyotrophic lateral sclerosis (ALS). In order to investigate its functional role in the pathogenesis of ALS, we designed fusion proteins of two SOD1 monomers linked by a polypeptide. We demonstrated that wild-type-like mutants, but not SOD1(G85R) homodimers, as well as mutant heterodimers including SOD1(G85R)-SOD1(hWT) display dismutase activity. Mutant homodimers showed an increased aggregation compared with the corresponding heterodimers in cell cultures and transgenic Caenorhabditis elegans, although SOD1(G85R) heterodimers are more toxic in functional assays. Our data show that (i) toxicity of mutant SOD1 is not correlated to its aggregation potential; (ii) dismutase-inactive mutants form dismutase-active heterodimers with SOD1(hWT); (iii) SOD1(hWT) can be converted to contribute to disease by forming active heterodimers. Therefore, we conclude that toxicity of mutant SOD1 is at least partially mediated through heterodimer formation with SOD1(hWT) in vivo and does not correlate with the aggregation potential of individual mutants.

References

Jan 1, 1975·Annual Review of Biochemistry·I Fridovich
Aug 1, 1973·Virology·F L Graham, A J van der Eb
Sep 26, 1995·Proceedings of the National Academy of Sciences of the United States of America·C D Link
Aug 16, 1994·Proceedings of the National Academy of Sciences of the United States of America·D R BorcheltD W Cleveland
Aug 12, 1993·Nature·J S BeckmanW H Koppenol
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·C R Robinson, R T Sauer
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·P PasinelliR H Brown
May 17, 2000·Proceedings of the National Academy of Sciences of the United States of America·S H SatyalR I Morimoto
Mar 13, 2002·Nature Neuroscience·Jamuna R SubramaniamPhilip C Wong
Sep 5, 2002·Molecular Genetics and Metabolism·Nicole C Christacos, Judith L Fridovich-Keil
May 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·P B StathopulosE M Meiering
Oct 10, 2003·Brain : a Journal of Neurology·P Andreas JonssonStefan L Marklund
Apr 2, 2004·Proceedings of the National Academy of Sciences of the United States of America·Michael A HoughS Samar Hasnain
Jun 15, 2005·Annual Review of Biochemistry·Joan Selverstone ValentineSoshanna Zittin Potter
Jul 1, 2005·Proceedings of the National Academy of Sciences of the United States of America·Mikael J LindbergMikael Oliveberg
Feb 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Christopher M SchonhoffJoan B Mannick
Apr 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yoshiaki FurukawaThomas V O'Halloran
Apr 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Han-Xiang DengTeepu Siddique
May 23, 2006·Biochimica Et Biophysica Acta·Siân C BarberPamela J Shaw
Jun 3, 2006·Science·Séverine BoilléeDon W Cleveland
Jun 27, 2006·Journal of Cellular and Molecular Medicine·Isabella Dalle-DonneAldo Milzani
Jun 30, 2006·Experimental Neurology·J KrishnanL Van Den Bosch
Oct 4, 2006·Neuron·Séverine BoilléeDon W Cleveland
Mar 29, 2007·Proceedings of the National Academy of Sciences of the United States of America·Marjatta SonJeffrey L Elliott

❮ Previous
Next ❯

Citations

Feb 3, 2009·Molecular Neurobiology·Kohsuke KanekuraMasaaki Matsuoka
Mar 21, 2012·Proceedings of the National Academy of Sciences of the United States of America·Terrell E BrothertonJonathan D Glass
Jul 29, 2010·The Journal of Biological Chemistry·Mary Anne SahawnehAlvaro G Estévez
Jun 22, 2010·Antioxidants & Redox Signaling·Melissa NassifClaudio Hetz
Nov 19, 2011·Molecular Neurodegeneration·Mercedes Prudencio, David R Borchelt
Nov 28, 2012·Journal of Cell Science·Jelena KoracIvan Dikic
Jul 15, 2009·Experimental Biology and Medicine·Sai V SeetharamanP John Hart
Sep 28, 2010·Human Molecular Genetics·Mercedes PrudencioDavid R Borchelt
Jun 25, 2010·Neurobiology of Disease·Jean-Nicolas AudetJean-Pierre Julien
Jul 30, 2014·Journal of Neurochemistry·Christof HiebelChristian Behl
Jun 10, 2010·The European Journal of Neuroscience·André Bento-AbreuWim Robberecht
Oct 12, 2013·Biotechnology and Bioengineering·Simpson GregoireInchan Kwon
Jan 29, 2009·Proceedings of the National Academy of Sciences of the United States of America·Khanh T NguyenGavriel David
Nov 10, 2013·Neurobiology of Disease·Anna WeichertAlbrecht M Clement
Aug 29, 2012·Neurobiology of Disease·Terrell E BrothertonJonathan D Glass
Apr 16, 2013·Biochemical and Biophysical Research Communications·Yongmin KimSeongman Kang
May 23, 2014·Frontiers in Cellular Neuroscience·Piia VehviläinenGoldsteins Gundars
Aug 2, 2014·Journal of Molecular Biology·Sean NeddAnastassia N Alexandrova
Apr 24, 2020·Cellular and Molecular Life Sciences : CMLS·Anna S BesemerAlbrecht M Clement
Mar 20, 2015·The Journal of Biological Chemistry·Eugene Serebryany, Jonathan A King
Oct 20, 2020·The Journal of Clinical Investigation·Jonathan D Glass
Mar 1, 2021·Pharmacology Research & Perspectives·Sebastián GiuntiMaría José De Rosa
Jan 1, 2020·Translational Medicine of Aging·Kate M Van Pelt, Matthias C Truttmann
Aug 25, 2021·MSystems·Lizett Ortiz de Ora, Elizabeth N Bess

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.